Synthesis and antitumor activity of 5-[1-(3-(dimethylamino) propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2, 4-dimethyl-1H-pyrrole-3-carboxamides
We report herein the design and synthesis of novel 1-[3-(dimethylamino) propyl] indolin-2- one derivatives based on the structural features of Sunitinib, a known multitargeted receptor tyrosine kinase inhibitor, and TMP-20, a previously discovered compound with good antitumor activity in our lab. These newly synthesized derivatives were evaluated for in vitro activity against five human cancer cell lines and VEGF/bFGF-stimulated HUVECs. Results ...